P-58 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria – BERING CRC
| Autor: | Stintzing, S. 1, Hübner, G. 2, Schröder, J. 3, Kisro, J. 4, Welslau, M. 5, Bürkle, D. 6, Göhler, T. 7, Schmidt, B. 8, Müller-Huesmann, H. 9, Krammer-Steiner, B. 10, von der Heyde, E. 11, Reichenbach, F. 12, Arnold, D. 13, Gerger, A. 14, Hegewisch-Becker, S. 15, Vogel, A. 16, Winder, T. 17, Prager, G. 18 |
|---|---|
| Zdroj: | In Annals of Oncology July 2021 32 Supplement 3:S116-S116 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|